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The prognosis of patients with malignant glioma remains extremely poor despite
surgery and improvements in radio- and chemo-therapies. Thus, treatment strategies
that specifically target these tumors have the potential to greatly improve
therapeutic outcomes. "Marrow-isolated adult multilineage inducible" cells (MIAMI
cells) are a subpopulation of mesenchymal stromal cells (MSCs) which possess the
ability to migrate to brain tumors. We have previously shown that MIAMI cells were
able to efficiently incorporate lipid nanocapsules (LNCs) without altering either their
stem cell properties or their migration capacity. In this study, we assessed whether
the cytotoxic effects of MIAMI cells loaded with LNCs containing an organometallic
complex (ferrociphenol or Fc-diOH) could be used to treat brain tumors. The results
showed that MIAMI cells internalized Fc-diOH-LNCs and that this internalization did
not induce MIAMI cell death. Furthermore, Fc-diOH-LNC-loaded MIAMI cells
produced a cytotoxic effect on U87MG glioma cells in vitro. This cytotoxic effect was
validated in vivo after intratumoral injection of Fc-diOH-LNC-loaded MIAMI cells in
a heterotopic U87MG glioma model in nude mice. These promising results open up a
new field of treatment in which cellular vehicles and nanoparticles can be combined
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